A carregar...

Castration-resistant prostate cancer: latest evidence and therapeutic implications

Medical oncologists who treat men with castration-resistant prostate cancer (CRPC) have seen an abundance of new agents approved by the United States Food and Drug Administration in the last decade for a disease that was previously difficult to treat after becoming resistant to androgen-deprivation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Daniel L. Suzman, Emmanuel S. Antonarakis
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publishing 2014-07-01
Colecção:Therapeutic Advances in Medical Oncology
Acesso em linha:https://doi.org/10.1177/1758834014529176
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!